the challenges of implementing gene therapies for hemophilia in clinical practice
Published 1 year ago • 154 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
3:05
key challenges with implementing gene therapies in clinical practice for hemophilia
-
10:42
a detailed overview of the current and emerging gene therapies for hemophilia a & b
-
1:11
improving outcomes for hemophilia patients through the implementation of gene therapies
-
1:36
exigency study: exploring the impact of steroids following gene therapy for hemophilia
-
3:57
first-in-human gene therapy study of bay 2599023 in severe hemophilia a
-
6:48
an overview of the remaining challenges for patients with hemophilia
-
8:21
patient perspective: hemophilia b and gene therapy
-
4:48
gene therapy: the future of hemophilia treatment
-
10:23
how the gene therapy for hemophilia b got fda approval (the hope-b trial)
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
1:35
improved quality of life in patients with hemophilia a following gene therapy
-
2:23
current hurdles in aav-based gene therapy for hemophilia
-
1:43
quality of life in patients with hemophilia: the impact of bleeds & the benefits of gene therapy
-
18:10
gene therapy for hemophilia
-
1:09
highlights from isth: gene therapy in hemophilia a & undiagnosed bleeding disorders in pediatrics
-
3:22
the future generations of gene therapy for hemophilia
-
3:38
gene therapy: an end to hemophilia
-
0:51
empowering patients with hemophilia to make choices about gene therapy
-
1:12
promising novel agents for hemophilia a/b: gene therapies and extended half-life products
-
1:18
exigency sub-study: supporting patients with hemophilia when gene therapy is not an option